2026-03-03 00:00:00:0本报记者 靳 博3014316710http://paper.people.com.cn/rmrb/pc/content/202603/03/content_30143167.htmlhttp://paper.people.com.cn/rmrb/pad/content/202603/03/content_30143167.html11921 走，一起听戏去！（新春走基层）
How does a Congress that promises lower prices end up weakening the bargaining tools that restrain them? The answer lies less in ideology than in political incentives. Pharmacy benefit managers (PBMs) are opaque intermediaries—and they are unpopular with figures including Mark Cuban, who told Fortune that the way they bargain over drug prices is absurd, something that would never happen at the very same pharmacies buying a package of Pringles potato-chip products. (Cuban has been working to directly disrupt the PBM space with his business, Cost Plus Drugs.)
，推荐阅读夫子获取更多信息
本次增资的定价并未采用独立评估，而是以2022年B轮增资后的估值为基础协商确定，31.015亿元的投前估值与三年前持平，未出现明显溢价。，更多细节参见搜狗输入法下载
国务院副总理何立峰，最高人民法院院长张军，最高人民检察院检察长应勇，国家监察委员会负责同志，全国人大各专门委员会成员，各省区市人大常委会负责同志，部分副省级城市人大常委会主要负责同志，有关部门负责同志等列席会议。